Stephen Sander

1.7k total citations
47 papers, 1.3k citations indexed

About

Stephen Sander is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Epidemiology. According to data from OpenAlex, Stephen Sander has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cardiology and Cardiovascular Medicine, 19 papers in Economics and Econometrics and 10 papers in Epidemiology. Recurrent topics in Stephen Sander's work include Atrial Fibrillation Management and Outcomes (31 papers), Health Systems, Economic Evaluations, Quality of Life (19 papers) and Cardiac Arrhythmias and Treatments (10 papers). Stephen Sander is often cited by papers focused on Atrial Fibrillation Management and Outcomes (31 papers), Health Systems, Economic Evaluations, Quality of Life (19 papers) and Cardiac Arrhythmias and Treatments (10 papers). Stephen Sander collaborates with scholars based in United States, France and Germany. Stephen Sander's co-authors include Craig I Coleman, Deborah Cios, William L. Baker, C Michael White, Jeffrey Kluger, Kimberly Siu, David Walker, Aarti Patel, Sachin A. Shah and David B. Matchar and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Stephen Sander

46 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen Sander United States	18	915	343	218	138	111	47	1.3k
Marjorie E. Zettler United States	19	514 0.6×	86 0.3×	130 0.6×	50 0.4×	118 1.1×	64	1.1k
Carlos Escobar Spain	22	1.4k 1.6×	173 0.5×	121 0.6×	116 0.8×	106 1.0×	199	2.0k
Ján Murín Slovakia	15	782 0.9×	49 0.1×	139 0.6×	96 0.7×	99 0.9×	84	1.2k
Juan Cosín Spain	18	997 1.1×	75 0.2×	75 0.3×	61 0.4×	52 0.5×	63	1.2k
Pernille Buch Denmark	12	1.2k 1.4×	82 0.2×	151 0.7×	137 1.0×	101 0.9×	14	1.9k
Elliot M. Antman United States	19	1.2k 1.3×	201 0.6×	35 0.2×	81 0.6×	103 0.9×	36	1.5k
Gianna Fabbri Italy	14	931 1.0×	49 0.1×	44 0.2×	107 0.8×	63 0.6×	36	1.1k
Sarah Young United States	11	1.3k 1.5×	27 0.1×	65 0.3×	40 0.3×	104 0.9×	32	1.6k
Chern‐En Chiang Taiwan	32	3.0k 3.3×	324 0.9×	175 0.8×	210 1.5×	272 2.5×	129	3.4k
Giovanni B. Ambrosio Italy	20	762 0.8×	149 0.4×	50 0.2×	102 0.7×	273 2.5×	36	1.3k

Countries citing papers authored by Stephen Sander

Since Specialization

Citations

This map shows the geographic impact of Stephen Sander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Sander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Sander more than expected).

Fields of papers citing papers by Stephen Sander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Sander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Sander. The network helps show where Stephen Sander may publish in the future.

Co-authorship network of co-authors of Stephen Sander

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Sander. A scholar is included among the top collaborators of Stephen Sander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Sander. Stephen Sander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Willey, Vincent J., et al.. (2018). Treatment and persistence with oral anticoagulants among newly diagnosed patients with non-valvular atrial fibrillation: a retrospective observational study in a US commercially insured and Medicare Advantage population. BMJ Open. 8(6). e020676–e020676. 14 indexed citations

Ghate, Sameer R., et al.. (2017). Healthcare utilization and costs for patients initiating Dabigatran or Warfarin. Health and Quality of Life Outcomes. 15(1). 128–128. 8 indexed citations

Gilligan, Adrienne M., Pranav Gandhi, Xue Song, et al.. (2017). All-Cause, Stroke-, and Bleed-Specific Healthcare Costs: Comparison among Patients with Non-Valvular Atrial Fibrillation (NVAF) Newly Treated with Dabigatran or Warfarin. American Journal of Cardiovascular Drugs. 17(6). 481–492. 10 indexed citations

Jain, Rahul, et al.. (2016). Abstract 15102: Treatment and Persistence With Oral Anticoagulants Among Newly Diagnosed Patients With Non-Valvular Atrial Fibrillation in a Commercially Insured and Medicare Advantage Population. Circulation.

Francis, Kevin, Yu Chen, Stephen Sander, et al.. (2015). Healthcare utilization and costs associated with dabigatran compared to warfarin treatment in newly diagnosed patients with non-valvular atrial fibrillation. Current Medical Research and Opinion. 31(12). 2189–2195. 17 indexed citations

Clemens, Andreas, Siyang Peng, Martina Brueckmann, et al.. (2014). Efficacy and Cost-Effectiveness of Dabigatran Etexilate Versus Warfarin in Atrial Fibrillation in Different Age Subgroups. The American Journal of Cardiology. 114(6). 849–855. 19 indexed citations

Zalesak, Martin, Kimberly Siu, Kevin Francis, et al.. (2013). Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin. Circulation Cardiovascular Quality and Outcomes. 6(5). 567–574. 119 indexed citations

Johnson, Barbara H., Karen E. Smoyer‐Tomic, Kimberly Siu, et al.. (2013). Readmission among hospitalized patients with nonvalvular atrial fibrillation. American Journal of Health-System Pharmacy. 70(5). 414–422. 19 indexed citations

Song, Xue, Stephen Sander, Helen Varker, & Alpesh Amin. (2012). Patterns and Predictors of Use of Warfarin and Other Common Long-Term Medications in Patients with Atrial Fibrillation. American Journal of Cardiovascular Drugs. 12(4). 245–253. 23 indexed citations

10.

Smoyer‐Tomic, Karen E., Kimberly Siu, David Walker, et al.. (2012). Anticoagulant Use, the Prevalence of Bridging, and Relation to Length of Stay among Hospitalized Patients with Non-Valvular Atrial Fibrillation. American Journal of Cardiovascular Drugs. 12(6). 403–413. 18 indexed citations

11.

Burke, James, et al.. (2012). Health Care Utilization and Costs in Type 2 Diabetes Mellitus and Their Association with Renal Impairment. Postgraduate Medicine. 124(2). 77–91. 15 indexed citations

12.

Chen, Shih‐Yin, Kimberly Siu, Birgit Kovacs, et al.. (2012). Clinical and economic outcomes associated with National Kidney Foundation guideline-concordant oral antidiabetic drug treatment among type 2 diabetes patients with chronic kidney disease. Current Medical Research and Opinion. 28(4). 493–501. 13 indexed citations

13.

Mercaldi, Catherine J., Beth Hahn, Matthew W. Reynolds, et al.. (2010). Cost Efficiency of Anticoagulation With Warfarin to Prevent Stroke in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation. Stroke. 42(1). 112–118. 69 indexed citations

14.

Baker, William L., Deborah Cios, Stephen Sander, & Craig I Coleman. (2009). Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States. Journal of Managed Care Pharmacy. 15(3). 244–252. 313 indexed citations

15.

White, C Michael, Stephen Sander, Craig I Coleman, et al.. (2007). Impact of Epicardial Anterior Fat Pad Retention on Postcardiothoracic Surgery Atrial Fibrillation Incidence. Journal of the American College of Cardiology. 49(3). 298–303. 39 indexed citations

16.

Shah, Sachin A., et al.. (2007). Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. The Lancet Infectious Diseases. 7(7). 473–480. 112 indexed citations

17.

Coleman, Craig I, Jeffrey Kluger, Krista M. Dale, et al.. (2007). Impact of amiodarone on the ability of anterior fat pad retention to prevent postcoronary arterial bypass grafting atrial fibrillation incidence: a substudy of the AFIST III (Atrial Fibrillation Suppression Trial III). Expert Opinion on Pharmacotherapy. 9(1). 7–13. 1 indexed citations

18.

Sander, Stephen, et al.. (2007). Cost–effectiveness of antiplatelet therapy for secondary stroke prevention. Expert Review of Pharmacoeconomics & Outcomes Research. 7(4). 357–363. 2 indexed citations

19.

Sander, Stephen, Craig I Coleman, Aarti Patel, Jeffrey Kluger, & C Michael White. (2006). The Impact of Coenzyme Q10 on Systolic Function in Patients With Chronic Heart Failure. Journal of Cardiac Failure. 12(6). 464–472. 125 indexed citations

20.

Sander, Stephen, C Michael White, & Craig I Coleman. (2006). Comparative Safety and Efficacy of Urokinase and Recombinant Tissue Plasminogen Activator for Peripheral Arterial Occlusion: A Meta‐Analysis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(1). 51–60. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact